Cargando…

MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34(+) Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia

OBJECTIVE: In patients with type 2 diabetes (T2D) and critical limb ischemia (CLI), migration of circulating CD34(+) cells predicted cardiovascular mortality at 18 months after revascularization. This study aimed to provide long-term validation and mechanistic understanding of the biomarker. RESEARC...

Descripción completa

Detalles Bibliográficos
Autores principales: Spinetti, Gaia, Sangalli, Elena, Tagliabue, Elena, Maselli, Davide, Colpani, Ornella, Ferland-McCollough, David, Carnelli, Franco, Orlando, Patrizia, Paccagnella, Agostino, Furlan, Anna, Stefani, Piero Maria, Sambado, Luisa, Sambataro, Maria, Madeddu, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305013/
https://www.ncbi.nlm.nih.gov/pubmed/32358022
http://dx.doi.org/10.2337/dc19-2227
Descripción
Sumario:OBJECTIVE: In patients with type 2 diabetes (T2D) and critical limb ischemia (CLI), migration of circulating CD34(+) cells predicted cardiovascular mortality at 18 months after revascularization. This study aimed to provide long-term validation and mechanistic understanding of the biomarker. RESEARCH DESIGN AND METHODS: The association between CD34(+) cell migration and cardiovascular mortality was reassessed at 6 years after revascularization. In a new series of T2D-CLI and control subjects, immuno-sorted bone marrow CD34(+) cells were profiled for miRNA expression and assessed for apoptosis and angiogenesis activity. The differentially regulated miRNA-21 and its proapoptotic target, PDCD4, were titrated to verify their contribution in transferring damaging signals from CD34(+) cells to endothelial cells. RESULTS: Multivariable regression analysis confirmed that CD34(+) cell migration forecasts long-term cardiovascular mortality. CD34(+) cells from T2D-CLI patients were more apoptotic and less proangiogenic than those from control subjects and featured miRNA-21 downregulation, modulation of several long noncoding RNAs acting as miRNA-21 sponges, and upregulation of the miRNA-21 proapoptotic target PDCD4. Silencing miR-21 in control CD34(+) cells phenocopied the T2D-CLI cell behavior. In coculture, T2D-CLI CD34(+) cells imprinted naive endothelial cells, increasing apoptosis, reducing network formation, and modulating the TUG1 sponge/miRNA-21/PDCD4 axis. Silencing PDCD4 or scavenging reactive oxygen species protected endothelial cells from the negative influence of T2D-CLI CD34(+) cells. CONCLUSIONS: Migration of CD34(+) cells predicts long-term cardiovascular mortality in T2D-CLI patients. An altered paracrine signaling conveys antiangiogenic and proapoptotic features from CD34(+) cells to the endothelium. This damaging interaction may increase the risk for life-threatening complications.